News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,413 Results
Type
Article (41391)
Company Profile (263)
Press Release (689744)
Multimedia
Podcasts (92)
Webinars (20)
Section
Business (204861)
Career Advice (2032)
Deals (35592)
Drug Delivery (130)
Drug Development (81535)
Employer Resources (173)
FDA (16513)
Job Trends (14984)
News (346869)
Policy (32751)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2598)
Accelerated approval (49)
Adcomms (27)
Allergies (171)
Alliances (49583)
ALS (212)
Alzheimer's disease (1801)
Antibody-drug conjugate (ADC) (465)
Approvals (16917)
Artificial intelligence (671)
Autoimmune disease (297)
Automation (56)
Bankruptcy (362)
Best Places to Work (11635)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (170)
Bladder cancer (198)
Brain cancer (72)
Breast cancer (761)
Cancer (5891)
Cardiovascular disease (477)
Career advice (1726)
Career pathing (43)
CAR-T (333)
CDC (56)
Celiac Disease (3)
Cell therapy (909)
Cervical cancer (47)
Clinical research (70921)
Collaboration (2075)
Company closure (5)
Compensation (1412)
Complete response letters (80)
COVID-19 (2743)
CRISPR (108)
C-suite (1139)
Cystic fibrosis (152)
Data (8019)
Decentralized trials (3)
Denatured (28)
Depression (161)
Dermatology (89)
Diabetes (588)
Diagnostics (6940)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (323)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (286)
Earnings (92139)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119693)
Executive appointments (1084)
FDA (20275)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1736)
Gene editing (234)
Generative AI (56)
Gene therapy (725)
GLP-1 (1058)
Government (4732)
Grass and pollen (6)
Guidances (408)
Healthcare (19019)
HIV (80)
Huntington's disease (56)
IgA nephropathy (98)
Immunology and inflammation (290)
Immuno-oncology (93)
Indications (196)
Infectious disease (3086)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (292)
Interviews (319)
IPO (16671)
IRA (50)
Job creations (3647)
Job search strategy (1431)
JPM (58)
Kidney cancer (19)
Labor market (102)
Layoffs (564)
Leadership (40)
Legal (7953)
Liver cancer (100)
Longevity (32)
Lung cancer (775)
Lymphoma (432)
Machine learning (60)
Management (59)
Manufacturing (1060)
MASH (190)
Medical device (13942)
Medtech (14070)
Mergers & acquisitions (20179)
Metabolic disorders (1510)
mRNA (210)
Multiple sclerosis (189)
NASH (17)
Neurodegenerative disease (422)
Neuropsychiatric disorders (105)
Neuroscience (3325)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4531)
Now hiring (78)
Obesity (707)
Opinion (288)
Ovarian cancer (226)
Pain (258)
Pancreatic cancer (310)
Parkinson's disease (367)
Partnered (33)
Patents (599)
Patient recruitment (676)
Peanut (62)
People (59623)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22105)
Phase 2 (31252)
Phase 3 (23242)
Pipeline (8925)
Policy (319)
Postmarket research (2569)
Preclinical (9423)
Press Release (64)
Prostate cancer (308)
Psychedelics (54)
Radiopharmaceuticals (326)
Rare diseases (1085)
Real estate (5972)
Recruiting (70)
Regulatory (25452)
Reports (56)
Research institute (2413)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (178)
Series A (289)
Series B (214)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3641)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (62)
Vaccines (1098)
Venture capital (110)
Weight loss (454)
Women's health (128)
Worklife (20)
Date
Today (22)
Last 7 days (523)
Last 30 days (3301)
Last 365 days (30081)
2026 (13142)
2025 (30176)
2024 (35208)
2023 (40072)
2022 (51173)
2021 (55707)
2020 (54081)
2019 (46537)
2018 (35017)
2017 (32110)
2016 (31482)
2015 (37552)
2014 (31319)
2013 (26348)
2012 (28572)
2011 (29265)
2010 (27328)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (39734)
Australia (6512)
California (13402)
Canada (3802)
China (1365)
Colorado (569)
Connecticut (579)
Delaware (413)
Europe (85956)
Florida (2008)
Georgia (430)
Hawaii (3)
Idaho (62)
Illinois (1059)
India (90)
Indiana (605)
Iowa (23)
Japan (544)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1601)
Massachusetts (9552)
Michigan (366)
Minnesota (726)
Mississippi (6)
Missouri (145)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3515)
New Mexico (29)
New York (3497)
North Carolina (1695)
North Dakota (9)
Northern California (6732)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2692)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5289)
Tennessee (214)
Texas (2132)
United States (47214)
Utah (398)
Vermont (1)
Virginia (323)
Washington D.C. (80)
Washington State (1066)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
731,413 Results for "3sbio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pfizer Completes Licensing Agreement with 3SBio
July 25, 2025
·
7 min read
Press Releases
Pfizer Enters into Exclusive Licensing Agreement with 3SBio
May 20, 2025
·
7 min read
Cancer
Pfizer Puts $6B on the Line for 3SBio’s PD-1/VEGF Antibody
The deal comes three months after Pfizer inked a PD-1/VEGF partnership with Summit Therapeutics, leading BMO Capital Markets to express confusion regarding the pharma’s overall strategy.
May 20, 2025
·
2 min read
·
Tristan Manalac
Business
3SBio announces 2022 annual results, with revenue rising 7.5% year on year and normalized net profit attributable to parents jumping 25.2%
Chinese leading biopharmaceutical company 3SBio announced its 2022 annual results.
March 21, 2023
·
10 min read
Numab and 3SBio’s Sunshine Guojian Expand Partnership to Develop Novel T Cell Engager NM28
Numab Therapeutics AG and 3SBio Inc. announced that 3SBio’s subsidiary Sunshine Guojian Pharmaceutical Co., Ltd. exercised its option for an exclusive regional license for the development and commercialization of NM28, a potential best-in-class bivalent mesothelin -targeting CD3 T cell engager.
December 14, 2021
·
4 min read
Press Releases
Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)
May 15, 2026
·
1 min read
Press Releases
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
May 20, 2026
·
1 min read
Press Releases
Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace
May 13, 2026
·
3 min read
Press Releases
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
May 19, 2026
·
4 min read
Press Releases
Exagen Inc. Reports First Quarter 2026 Results
May 11, 2026
·
10 min read
1 of 73,142
Next
